40.5 million dirhams, net profit, during 2024
Ras Al Khaimah, February 14 / WAM / Gulf Pharmaceutical Industries Company – Julphar announced a net profit of 40.5 million dirhams for the year 2024, supported by sustainable growth and operational efficiency, reflecting the strong performance of the company during the year.
Julphar recorded revenues of 1.31 billion dirhams, achieving 2.7% growth compared to the same period last year, and 4% on the basis of the fixed currency, and operating profits increased before interest, taxes and consumption to 144.9 million dirhams, driven by successful strategic initiatives.
The company achieved strong operational cash flows of 245.6 million dirhams, compared to 93.6 million dirhams in the previous year, thanks to the effective management of working capital and the promotion of profitability.
Sheikh Saqr bin Humaid Al Qasimi, Chairman of the Board of Directors of the Gulf Pharmaceutical Industries Company “Julphar”, stressed that while we serve millions of patients across various therapeutic fields, we are confident that the growth mentality that we adopt and our focus on innovation, cooperation and geographical expansion will enable us to achieve a sustainable positive impact in the sector Health care and knowledge economy in the Arab Gulf region and abroad.
He added that the growth strategy 2030 directs the company’s commitment to providing excellence through pioneering markets in the market and value -added products.
For his part, Basil Ziada, CEO of the company, explained that the transformations in the business model have strengthened the group’s ability to implement its strategy efficiently and achieve a sustainable value for shareholders, stressing the company’s continued enhancement of its position in the global markets.
HD –
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
